STERIS plc (NYSE:STE) Declares Quarterly Dividend of $0.63

STERIS plc (NYSE:STE) announced a quarterly dividend on Wednesday, January 28th. Shareholders of record on Tuesday, February 17th will be given a dividend of 0.63 per share by the medical equipment provider on Thursday, March 19th. This represents a c) annualized dividend and a yield of 1.0%. The ex-dividend date of this dividend is Tuesday, February 17th.

STERIS has increased its dividend payment by an average of 0.1%per year over the last three years and has increased its dividend annually for the last 20 consecutive years. STERIS has a payout ratio of 22.9% indicating that its dividend is sufficiently covered by earnings. Analysts expect STERIS to earn $9.93 per share next year, which means the company should continue to be able to cover its $2.52 annual dividend with an expected future payout ratio of 25.4%.

STERIS Price Performance

Shares of STE stock traded down $2.85 on Thursday, reaching $258.02. The company’s stock had a trading volume of 151,242 shares, compared to its average volume of 452,958. The company has a quick ratio of 1.63, a current ratio of 2.37 and a debt-to-equity ratio of 0.27. The stock’s 50 day simple moving average is $259.21 and its 200-day simple moving average is $248.25. The company has a market capitalization of $25.32 billion, a P/E ratio of 37.16 and a beta of 1.03. STERIS has a 12-month low of $204.90 and a 12-month high of $269.44.

STERIS (NYSE:STE) last announced its earnings results on Wednesday, November 5th. The medical equipment provider reported $2.47 earnings per share for the quarter, beating analysts’ consensus estimates of $2.38 by $0.09. The business had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.43 billion. STERIS had a net margin of 12.07% and a return on equity of 14.43%. During the same period last year, the firm posted $2.14 earnings per share. STERIS has set its FY 2026 guidance at 10.150-10.30 EPS. As a group, equities analysts predict that STERIS will post 9.08 earnings per share for the current fiscal year.

Insider Buying and Selling

In other STERIS news, VP Julia Madsen sold 5,008 shares of the firm’s stock in a transaction that occurred on Friday, November 21st. The shares were sold at an average price of $262.00, for a total transaction of $1,312,096.00. Following the completion of the transaction, the vice president owned 10,710 shares of the company’s stock, valued at approximately $2,806,020. This trade represents a 31.86% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, VP John Adam Zangerle sold 15,000 shares of the firm’s stock in a transaction that occurred on Tuesday, November 11th. The shares were sold at an average price of $265.14, for a total value of $3,977,100.00. Following the transaction, the vice president directly owned 33,669 shares of the company’s stock, valued at approximately $8,926,998.66. This trade represents a 30.82% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 25,044 shares of company stock valued at $6,586,218 over the last ninety days. Company insiders own 1.07% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. Norges Bank purchased a new stake in shares of STERIS during the 2nd quarter valued at about $289,132,000. AQR Capital Management LLC boosted its position in shares of STERIS by 178.6% in the third quarter. AQR Capital Management LLC now owns 1,183,070 shares of the medical equipment provider’s stock worth $291,704,000 after purchasing an additional 758,423 shares during the period. Boston Partners purchased a new stake in STERIS in the 3rd quarter worth $158,982,000. Orbis Allan Gray Ltd boosted its stake in STERIS by 36.0% in the 2nd quarter. Orbis Allan Gray Ltd now owns 2,100,099 shares of the medical equipment provider’s stock worth $504,486,000 after purchasing an additional 556,088 shares during the period. Finally, Thrivent Financial for Lutherans boosted its position in shares of STERIS by 246.4% during the third quarter. Thrivent Financial for Lutherans now owns 553,834 shares of the medical equipment provider’s stock worth $137,041,000 after acquiring an additional 393,970 shares during the last quarter. 94.69% of the stock is owned by hedge funds and other institutional investors.

STERIS Company Profile

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.